key: cord-0988953-edu1zuzt authors: Zhao, Bing; Ni, Chao; Gao, Ran; Wang, Yuyan; Yang, Li; Wei, Jinsong; Lv, Ting; Liang, Jianqing; Zhang, Qisheng; Xu, Wei; Xie, Youhua; Wang, Xiaoyue; Yuan, Zhenghong; Liang, Junbo; Zhang, Rong; Lin, Xinhua title: Recapitulation of SARS-CoV-2 Infection and Cholangiocyte Damage with Human Liver Organoids date: 2020-03-17 journal: bioRxiv DOI: 10.1101/2020.03.16.990317 sha: 8abeefb10db504d0fbf74c081f8c0c11fea1cca1 doc_id: 988953 cord_uid: edu1zuzt The newly emerged pandemic coronavirus, SARS-CoV-2, has posed a significant public health threat worldwide. However, the mode of virus transmission and tissue tropism is not well established yet. Recent findings of substantial liver damage in patients and ACE2+ cholangiocytes in healthy liver tissues prompted us to hypothesize that human liver ductal organoids could serve as a model to determine the susceptibility and mechanisms underlining the liver damage upon SARS-CoV-2 infection. By single-cell RNA sequencing, we found that long-term liver ductal organoid culture preserved the human specific ACE2+ population of cholangiocytes. Moreover, human liver ductal organoids were permissive to SARS-CoV-2 infection and support robust replication. Notably, virus infection impaired the barrier and bile acid transporting functions of cholangiocytes through dysregulation of genes involved in tight junction formation and bile acid transportation, which could explain the bile acid accumulation and consequent liver damage in patients. These results indicate that control of liver damage caused directly by viral infection should be valued in treating COVID-19 patients. Our findings also provide an application of human organoids in investigating the tropism and pathogenesis of SARS-CoV-2, which would facilitate novel drug discovery. A recent outbreak of SARS-CoV-2 (previously named 2019-nCoV) infection in 47 Wuhan (China) has caused emergent and significant threats to global public health 1 . 48 The dominant symptoms of coronavirus disease 2019 (COVID-19) are fever and 49 cough 2,3 . However, a proportion of patients showed multi-organ damage and 50 dysfunction 2-4 . Of note, liver damage is emerging as a co-existed symptom reported 51 in patients with COVID-19. A recent epidemiologic study in Shanghai (China) 52 reported that 75 out of 148 (50.7%) COVID-19 patients had liver function 53 abnormality, indicated by key liver function parameters above the normal range, 54 including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline 55 phosphatase (ALP) or total bilirubin (TBIL) 5 . A national wide clinical study collecting 56 1,099 COVID-19 patients revealed that around 20% of patients had elevated ALT and 57 AST and around 10% of patients had elevated TBIL. Especially, the percentage of 58 patients with liver damage is much higher in severe patients than that in non-severe 59 ones 2 . Although the clinical correlation has been implicated, it is still unclear whether 60 the liver damage is caused by direct virus infection in the liver or by systematic 61 reasons such as cytokine storm. ACE2+ cholangiocytes are preserved in human liver ductal organoid cultures. 88 To establish the SARS-CoV-2 infection model with human liver ductal organoids, 89 we first determined whether the long-term organoid culture could preserve the 90 ACE2+ cholangiocytes ex vivo. We processed single-cell RNA sequencing (scRNA-seq) 91 to interrogate the transcriptome of cholangiocytes in human liver ductal organoids. Recapitulation of SARS-CoV-2 infection in human Liver ductal organoids. 109 We next examined the susceptibility of human liver ductal organoids to Statistical analysis. 249 We employed Student's t-test or ANOVA test to analyze the parametric 250 experimental results. Significant differences were noted with asterisks. A new coronavirus associated with human respiratory disease in China Clinical features of patients infected with 2019 novel coronavirus in Wuhan Epidemiological and clinical characteristics of 99 cases of 2019 novel 278 coronavirus pneumonia in Wuhan, China: a descriptive study A Novel Coronavirus from Patients with Pneumonia in China Clinical Features of COVID-19 Related Liver Damage. medRxiv A pneumonia outbreak associated with a new coronavirus of probable bat 284 origin Receptor recognition by novel coronavirus 286 from Wuhan: An analysis based on decade-long structural studies of SARS Structure analysis of the receptor binding of 2019-nCoV Angiotensin-converting enzyme 2: a functional 291 receptor for SARS coronavirus SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by 294 a Clinically Proven Protease Inhibitor Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 296 2019-nCov. bioRxiv The digestive system is a potential route of 2019-nCov infection: a 298 bioinformatics analysis based on single-cell transcriptomes Single cell RNA sequencing of 13 human tissues identify 300 cell types and receptors of human coronaviruses Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 302 2019-nCoV Infection Pathological findings of COVID-19 associated with acute respiratory distress 304 syndrome Organoid culture systems to study host-pathogen interactions Long-term culture of genome-stable bipotent stem cells from adult human 308 liver The authors thank Dr. Stacey S. Huppert for technical assistance. We also wish to 253 acknowledge Di Qu, Xia Cai, Zhiping Sun, Wendong Han and the others at Biosafety